HSPB1 rs7459185与TGFB1 rs11466353单核苷酸多态性与肺癌放射性食管炎的关联
研究前瞻性纳入3家机构2012至2016年的247例肺癌患者,对TGFB1和HSPB1基因的7个SNP进行基因分型,分析其与放射性食管炎风险的关联。多因素分析显示,携带HSPB1 rs7459185 CC基因型者急性3级放射性食管炎风险显著高于GG/GC基因型者(HR=17.73);携带TGFB1 rs11466353 GG基因型者晚期2级放射性食管炎风险低于TT/TG基因型者(HR=0.29)。
要点
- HSPB1 rs7459185 CC基因型与急性3级放射性食管炎风险显著升高相关(HR=17.73)。
- TGFB1 rs11466353 GG基因型与晚期2级放射性食管炎风险降低相关(HR=0.29)。
- 上述基因型可能作为生物标志物与其他风险因素共同指导个体化治疗强度。
核心结论
- 肺癌患者中不同的rs7459185/rs11466353基因型与放射性食管炎风险相关,可能作为生物标志物与其他风险因素共同指导个体化治疗的强度。
研究设计与样本
- 前瞻性研究,2012至2016年从3家机构招募247例肺癌患者,对TGFB1和HSPB1基因的7个SNP进行基因分型,采用Kaplan-Meier累积概率和Cox比例风险分析评估基因型对放射性食管炎风险的影响。
主要发现
- 多因素分析显示,携带HSPB1 rs7459185 CC基因型的患者急性3级放射性食管炎风险显著高于GG/GC基因型携带者(HR=17.73;95%CI=2.896-108.49;p=0.002)。
- 接受食管受照30Gy体积高于中位值的肺癌患者中,携带rs7459185 GG/GC基因型者放射性食管炎发生率显著更低(p<0.001)。
- 携带TGFB1 rs11466353 GG基因型的肺癌患者晚期2级放射性食管炎风险低于TT/TG基因型携带者(HR=0.29;95%CI=0.103-0.830;p=0.021)。
- 接受高辐射剂量(>60Gy)且携带rs11466353 GG基因型的患者放射性食管炎发生率显著更低(p=0.025)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Radiochemotherapy (RCT) success in lung cancer (LC) can be limited due to the onset of adverse effects in the adjacent normal tissue such as radiation-induced esophageal toxicity (RIET). Therefore, specific biomarkers to customize the RCT dose administration and esophageal toxicity prediction are necessary to improve treatment effectiveness. MATERIALS AND METHODS: 247 LC patients prospectively recruited between 2012 and 2016 from 3 institutions were genotyped for 7 SNPs along TGFB1 and HSPB1 genes seeking an association with RIET risk development. Kaplan-Meier cumulative probability and Cox proportional hazards analyses were used to evaluate the effect of TGFB1 and HSPB1 genotypes on such risk. RESULTS: Multivariate analyses showed that patients carrying the HSPB1 rs7459185 CC genotype were associated with a significantly higher risk of acute grade 3 RIET than those carrying the GG/GC genotypes (HR = 17.73; 95% CI = 2.896-108.49; p = 0.002). LC patients who received higher (>median) volume of esophagus exposed to 30 Gy and harboring the rs7459185 GG/GC genotypes showed a significantly lower RIET incidence (p < 0.001). Additionally, LC patients carrying the TGFB1 rs11466353 GG genotype were found to be associated with a lower risk of late grade 2 RIET compared with those with the TT/TG genotypes (HR = 0.29; 95% CI = 0.103-0.830; p = 0.021). Patients receiving a high (>60 Gy) radiation dose who presented the rs11466353 GG genotype had a significantly lower RIET incidence (p = 0.025). CONCLUSION: The presence of different rs7459185/rs11466353 genotypes in LC patients associated with RIET risk and may be useful biomarkers along with other risk factors for guiding therapy intensity in an individualized therapy.
引用
- Delgado BD, Enguix-Riego MV, Fernández de Bobadilla JC, et al. Association of single nucleotide polymorphisms at HSPB1 rs7459185 and TGFB1 rs11466353 with radiation esophagitis in lung cancer. Radiother Oncol. 2019. PMID: 31015163. doi:10.1016/j.radonc.2019.03.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。